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Using standard genetic recombination techniques, studies in our laboratory suggest that recombination
rates are very high and vary in different portions of the mouse hepatitis virus (MHV) genome. To determine
the actual recombination frequencies in the MHV genome and localize the nucleotide boundaries of individual
viral genes, we have sequenced temperature-sensitive and revertant viruses to identify the location of specific
mutant alleles. Complementation group F RNA' ts mutants (LA7, NC6, and NC16) each contained a unique
mutation which was tightly linked to the ts phenotype and resulted in a conservative or nonconservative amino
acid change in the MHV S glycoprotein gene. In agreement with previous recombination mapping studies, the
mutation in LA7 and NC6 mapped within the Si domain while NC16 mapped within the S2 domain. To
determine the map coordinates of the MHV polymerase genes, several RNA- mutants and their revertants
belonging to complementation groups C (NC3 and LA9) and E (LA18 and NC4) were also sequenced.
Mutations were identified in each virus that were tightly linked to the ts phenotype and resulted in either a
conservative or nonconservative amino acid change. The group C allele spanned the ORF la/ORF lb junction,
while the group E mutants mapped at the C terminus of ORF lb about 20 to 22 kb from the 5' end of the
genome. Mutation rates, calculated from the reversion frequencies of plaque-purified ts viruses requiring a
single nucleotide alteration for reversion, approached 1.32 (± 0.89) 10-4 substitutions per nucleotide site
per round of template copying. Detailed recombination mapping studies across known distances between these
different ts alleles has confirmed that homologous recombination rates approached 25% and varied within
different portions of the MHV genome.
Mouse hepatitis virus (MHV), a member of the family
Coronaviridae, contains a single-stranded nonsegmented plus-
polarity RNA of about 32 kb in length (28, 39). The genomic
RNA is surrounded by a helical nucleocapsid structure con-
taining multiple copies of a 50-kDa phosphoprotein (N) (1,
47). The helical nucleocapsid is contained within a lipid
envelope containing two virus-specific glycoproteins: the 180-
kDa S and the 23-kDa M glycoproteins (50). Some strains of
MHV contain a 65-kDa hemagglutinin esterase (HE) (32, 46).
The MHV RNA polymerase genes are probably encoded in
two large open reading frames (ORFs), designated ORF la
and ORF lb, in the 5'-most 22 kb of the MHV genome.
Although the exact location and number of genetic alleles
encoded in gene 1 are not known, sequence analysis suggests
that ORF la contains a membrane anchoring domain, three
cysteine-rich domains, two papain-like protease motifs, and a
poliovirus 3C-like protease motif, while ORF lb contains
highly conserved polymerase, helicase, and metal binding
motifs typical of viral RNA polymerases (8, 9, 28). Six RNA-
complementation groups ofMHV have been isolated, and five
of these RNA- complementation groups map within the 22-kb
polymerase region of the MHV genome (5, 25, 29, 34, 43).
In addition to the polymerase genes, the genome of MHV
contains six to eight large ORFs which are expressed from
subgenomic-length mRNAs (26, 42, 45, 47, 48). These mRNAs
are arranged in the form of a nested set structure from the 3'
end of the genome and contain a unique leader RNA sequence
at the 5' end which is derived from the 5' end of the genome
(26, 42, 44, 48). Although still under study, considerable data
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suggest that the MHV subgenomic mRNAs are initially syn-
thesized by a unique discontinuous "leader priming" transcrip-
tion mechanism from a full-length negative-strand RNA and
subsequently amplified by mRNA replication or transcription
from subgenomic negative-stranded RNAs containing anti-
leaders (2, 7, 41, 44, 45). Each subgenomic mRNA encodes
one or more structural or nonstructural proteins, and a single
RNA' complementation group of MHV-A59 has been iso-
lated which maps within the S glycoprotein gene (15, 47).
During mixed infection, MHV undergoes RNA recombina-
tion at high frequency, a phenomenon which is probably
mediated by the large size of the genome, discontinuous
transcription, and the presence of transcriptionally active
subgenomic negative strands which contribute to increased
recombination rates at the 3' end of the genome (5, 6, 15, 24,
30). Recombination between the genomes of nonsegmented
RNA viruses also provides a convenient method to determine
the location and orientation of distinct genetic loci in the viral
genome, and genetic maps of polioviruses, apthoviruses, and
coronaviruses have been resolved (5, 14, 15, 27). Since previous
studies have suggested that the recombination frequency may
vary in different portions of the MHV genome (15), we
identified specific mutations which were tightly linked to the
temperature-sensitive (ts) phenotype in ts mutants of MHV-
A59 and determined precise recombination frequencies across
known distances in the MHV genome.
MATERLALS AND METHODS
Virus and cell culture. Temperature-sensitive mutants rep-
resenting the complementation group F RNA' mutants (NC6,
LA7, and NC16) as well as the group C (NC3 and LA9) and
group E (LA18 and NC4) RNA- mutants were used during
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the course of this study (15, 43). Viruses were plaque purified
two to three times, and stocks were propagated at 32°C in
150-cm2 flasks containing DBT cells as previously described (5,
43). To select for revertants of the group C and group E RNA-
mutants, virus stocks were plaque assayed at 39.5°C and
individual plaques were isolated and repurified by plaque assay
at the restrictive temperature. Individual stocks of revertant
virus were grown in 150-cm2 flasks at 37°C, and the reversion
frequencies were determined by plaque assay at 32 and 39.5°C.
Since it proved impossible to directly isolate NC4 revertants at
39.5°C, stock virus was passaged for three passages at 37°C and
one passage at 39.5°C, prior to the selection of a single plaque
at 39.5°C. After plaque purification as described, virus titers
were determined at 32 and 39.5°C by plaque assay.
DBT cells were maintained in Dulbecco's modified essential
medium containing 6% fetal calf serum, 1% gentamicin/kana-
mycin (GIBCO), and 5% tryptose phosphate broth. Plaque
assays were performed at either the permissive (32°C) or
nonpermissive (39.5°C) temperatures in DBT cells in medium
containing 0.8% agarose (BRL). Plates were stained with
neutral red at 28 to 36 h postinfection and counted.
Recombination analysis. Recombination frequencies were
determined as the percentage of ts+ progeny virus present
following a genetic cross between two different ts mutants at
the permissive temperature and reported as mean + standard
deviation as previously described (5, 14, 15, 27). Following
three to seven independent assays, standardized 1% recombi-
nation rates (in base pairs) were first adjusted to 1% by
dividing the recombination frequency for each independent
assay in a particular cross into the number of nucleotides
separating the two distinct genetic markers. Average rates
were determined, and all values were reported as mean base
pairs + standard deviation. To determine the overall recom-
bination rate in each region of the MHV genome, we averaged
the 1% recombination frequency in base pairs from all the
available assays in each particular cross with those from all
other crosses between ts mutants residing within the poly-
merase gene (NC3, LA9, LA18, and NC4) (n = 28), within the
S glycoprotein gene (NC6, LA7, and NC16) (n = 18), or
between the 3' end of the polymerase gene (group E: NC4 and
LA18) and the S glycoprotein gene (group F: NC6, LA7, and
NC16) (n = 22). Means + standard deviations were recorded
in each region of the genome. Statistically significant differ-
ences in recombination frequencies were identified by the
Student t test.
Intracellular RNA isolation and cDNA synthesis. Cultures
of DBT cells in 60-mm2 petri dishes were infected at a
multiplicity of infection of 5 with different ts mutants and their
respective revertants for 1 h. After the addition of medium,
intracellular RNA was harvested at 10 h postinfection with
RNA-STAT-60 (TEL-test "B", INC) as described by the
manufacturer. The purified RNA was precipitated under eth-
anol, washed, resuspended in TE buffer (10 mM Tris-HCl, pH
7.2, 1 mM EDTA), and used directly as a template for cDNA
synthesis.
Briefly, cDNA synthesis was accomplished in a 20-,ul reac-
tion mixture containing 1 ,ug of intracellular RNA, 4 p.l of 5x
first strand reaction buffer (BRL), 2 ,ul of 0.1 M dithiothreitol
(BRL), 1 ,u1 of 10 mM deoxynucleoside triphosphate (Phar-
macia), 200 U of Moloney murine leukemia virus reverse
transcriptase (BRL), and 1 U of RNase inhibitor (Promega)
for 1 h at 37°C. The cDNA products were precipitated in
ethanol and resuspended in 50 ,ul of deionized distilled H20.
PCR and subcloning strategies. The MHV S glycoprotein
and ORF lb genetic domains were cloned by PCR. Briefly,
three unique sets of overlapping primer pairs were used to
TABLE 1. Oligonucleotide primers designed for PCR of
ORF la and ORF lb in MHV
Name Oligomer (5'-3') Location (nt) Direction'
Pla TAGATGAGGCCAAGGC 12369-12384b +
Plb AAACGGAAGCACCACC 8671C -
P2a TGTGACCATGCTGGCAC 1-17c +
P2b TATCCACCATGGTGGG 1660-1645C -
P3a GAGGGGAGCTCCGTTG 1555-1570c +
P3b GGTCTCATCAGTAAAC 3021-3006C -
P4a TCAGATCCTGGACAGC 2955-3010c +
P4b ATACGGCGTTACTCCAACTG 4588-4569C -
P5a GGCCAGACTACACATGAGAG 4489-4508C +
P5b CATTACAGCCAGGGAGAT 60886071C -
P6a GGAACTGCAATGTGGAT 5996-6012c +
P6b GCTAGAGC-FlCATTACCGC 7073-7055C -
P7a GCCTIGAACCGAGCCATTA 6989-7007C +
P7b TTCACAGCCACGACAAGT 26-9 -
a +, sequence corresponding to mRNA strand; -, sequence complementary to
mRNA strand.
b Sequence described by Lee et al. (28).
c Sequence described by Bredenbeek et al. (9).
d Sequence described by Luytjes et al. (32).
clone the MHV S glycoprotein gene (15, 31). Seven additional
sets of overlapping primer pairs were synthesized from highly
conserved regions within the MHV A59/JHM ORF la and
ORF lb domains (9, 29) (Table 1). These primer pairs span the
entire ORF lb domain, as well as the 3'-most 1 kb of the ORF
la and the 5' end of the HE gene (32). Following cDNA
synthesis and 25 cycles of PCR, the DNA products were
separated on agarose gels, purified by Geneclean Kit II
(BiolOl, Inc.) as described by the manufacturer, and used
directly for subcloning or sequencing by asymmetric PCR.
PCR products were also subcloned into pGEM-T vector
system I (Promega) as described by the manufacturer. Follow-
ing ligation, the recombinant plasmid DNAs were transformed
into Escherichia coli DH5-competent cells (Stratagene) and
screened on LB plates containing 50 ,ug of ampicillin per ml,
100 mM IPTG (isopropyl-3-D-thiogalactopyranoside), and 100
,u of 2% X-Gal (5-bromo-4-chloro-3-indolyl-3-D-galactopyr-
anoside) (USB). Plasmid DNA was isolated and screened for
the presence of insert DNA by restriction mapping or oligo-
nucleotide probing.
For asymmetric PCR, 1/25 of the initial PCR product was
mixed with primer pairs added at a ratio of 1:100 (Primer
A/Primer B = 1/100). Following the addition of deoxynucleo-
side triphosphates and Taq polymerase and 25 PCR cycles, the
DNA product was predominantly single-stranded DNA which
was used directly for sequencing without further denaturation
(55).
Sequence analysis. DNA sequencing was accomplished by
the dideoxyribonucleotide chain termination method. For se-
quencing of double-stranded plasmid DNA, the DNA was
denatured with a 1:1 volume of 5 M NaOH for 5 min at 25°C
and then precipitated in 4/5 volume of 5 M NH4OAc and 1OX
volume of 100% ethanol for 10 min at -80°C. The samples
were precipitated by centrifugation and washed twice with 70%
ethanol before sequencing. The Sequenase Version 2.0 DNA
Sequencing Kit (USB) and [35S]dATP were used for sequenc-
ing as described by the manufacturer. The 1.0- to 1.5-kb PCR
products amplified with the oligonucleotide primer pairs de-
scribed in Table 1 were sequenced by using oligonucleotide
primers corresponding to nucleotides (nt) 12369 to 12384 or
12872 to 12887, or complementary to nt 12956 to 12941, in
ORF la (28) or corresponding to nt 1 to 16, 460 to 475, 1050
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TABLE 2. Complementation group C, E, and F ts and
revertant virus titers




LA18 6.08 x 107 2.43 x 103 4.05 x 10-5
LA18 Ri 2.25 x 107 9.50 x 106 4.02 x 10-1
LA18 R2 2.20 X 107 2.25 x 107 1.08 x 100
NC3 2.40 x 108 5.50 x 104 2.30 x 10-4
NC3 Ri 2.00 x 108 2.00 x 108 1.00 x 100
NC3 R2 1.90 X 108 1.80 x 108 9.50 x 10-1
NC4 1.20 X 107 <lo <8.30 X 10-7
NC4 Ri 7.00 x 106 5.2 x 106 0.70 x 10-1
LA9 8.60 x 107 7.75 x 103 9.68 x 10-5
LA9 Ri 2.85 x 107 1.00 X 107 3.50 x 10-1
LA9 R2 3.95 X 107 1.40 x 107 3.50 X 10-1
RNA' mutants
NC16 8.50 X 107 2.30 X 104 2.70 X 10-4
NC16 Ri 8.12 X 107 9.25 X 107 1.10 X 100
NC16 R2 1.00 X 108 9.00 X 107 0.90 X 10-1
NC6 2.83 X 107 3.52 x 103 1.2 X 10-4
NC6 Ri 2.30 x 107 2.40 X 107 1.00 X 10°
NC6 R2 1.57 X 107 2.12 X 107 1.35 X 100
LA7 2.70 X 107 1.00 X 103 3.70 X 10-5
LA7 Ri 6.98 X 107 8.73 x 107 1.25 X 100
LA7 R2 7.25 x 107 7.15 x 107 9.80 x 10-1
to 1065, 1555 to 1570, 2076 to 2091, 2453 to 2468, 2955 to 2970,
3502 to 3517, 3981 to 3996, 4489 to 4508, 4987 to 5002, 5470 to
5485, 5996 to 6012, 6482 to 6497, 6989 to 7007, 7497 to 7512,
or 8015 to 8030, or complementary to nt 86 to 71, 564 to 549,
1113 to 1098, 1660 to 1645, 2140 to 2125, 2558 to 2573, 3021 to
3006, 3550 to 3535, 4052 to 4037, 4588 to 4573, 5052 to 5037,
5504 to 5489, 6088 to 6071, 6508 to 6493, 7073 to 7058, 7527 to
7512, or 8068 to 8053, in ORF lb (9). Primers complementary
to nt 26 to 9 in ORF 2a were also used to sequence the very 3'
end of the polymerase gene (32). The oligonucleotides de-
signed for sequencing the S glycoprotein gene corresponded to
nt 2143 to 2160 in A59 gene 2 (32) and nt 642 to 662, 901 to
916, 1449 to 1465, 2078 to 2094, 2549 to 2564, 3012 to 3027, or
3524 to 3540 in A59 gene S. Complementary primers to nt 439
to 424, 677 to 662, 985 to 970, 1498 to 1481, 2115 to 2103, 2558
to 2537, 3078 to 3063, 3567 to 3551, or 4023 to 4008 were also
used in the S gene (31).
RESULTS
Temperature-sensitive and revertant virus of the C, E, and
F complementation groups ofMHV. All of the ts mutants used
in this study have been isolated and characterized previously in
our laboratory (5, 15, 43). Identification of the mutant allele in
MHV ts viruses is complicated by the large size of the viral
genome (31.6 kb) including a -22-kb polygenic polymerase
region at the 5' end of the genome which encodes six or more
distinct genetic domains functioning in RNA synthesis (5, 25,
29, 34, 39, 43). To simplify this problem, we initially focused
our studies on the RNA' ts mutants which mapped in the S
glycoprotein gene of MHV and the RNA- ts mutants which
were probably located near the 5' and 3' ends of the poly-
merase gene in ORF lb by recombination mapping techniques
(5). Since infectious vectors for MHV have not been devel-
oped, several revertant viruses were isolated by plaque purifi-
cation at the restrictive temperature for LA9, NC3, and LA18
to assist in the identification of the mutant allele. Revertants of
NC4 proved very difficult to isolate and required passage of the
virus at 37°C (three times) and 39°C (once) prior to the
isolation of a single plaque at 39°C. Revertants of the RNA'
ts mutants LA7, NC6, and NC16 have been previously pub-
lished (15).
Revertant viruses had similar titers, produced syncytia, and
were of the RNA' phenotype when assayed at both permissive
and restrictive temperatures (Table 2). When cultures were
infected and maintained at the restrictive temperature, the
replication of ts virus was inhibited while the revertant viruses
and MHV-A59 wild-type controls grew equally well at both
temperatures (15) (data not shown).
Sequence analysis of RNA' ts and revertant viruses. The
strategy for cloning and sequencing the ts and revertant viruses
is shown in Fig. 1. Unique sets of overlapping primer pairs
were developed to clone 1.0- to 1.5-kb stretches of viral RNA
in the MHV ORF lb and S glycoprotein genes by PCR (Table
1). To obviate potential PCR-induced mutations and high
polymerase error rates in RNA viruses (19), the PCR product
was reamplified by asymmetric PCR and the products were
sequenced directly as described in Materials and Methods.
This approach ensured that the "master sequence" of the virus
population will be determined. After identification of the
putative ts allele, wild-type A59, ts and revertant virus cDNA
products were subcloned into plasmid DNA and resequenced
to ensure the presence of the mutation or wild-type sequence
in independent clones. For the RNA' mutants (LA7, NC6,
and NC16), the entire S glycoprotein gene was sequenced in ts
and revertant viruses. For the RNA- mutants (NC4, LA18,
LA9, and NC3), the entire ORF lb region of the polymerase
gene was sequenced in ts and revertant viruses. In addition, the
3'-most 1 kb of ORF la of NC3 and LA9 was also sequenced
in the process of identifying the ts lesion. In all cases except
NC4, at least two independent revertants were sequenced to
demonstrate the location of the ts allele.
Among the group F RNA' mutants, NC6 contained a
nucleotide substitution at the 5' end of the S glycoprotein gene











FIG. 1. Cloning and sequencing strategy in the MHV ORF la and
ORF lb genes. The organization of the MHV genome is divided into
eight large ORFs designated 1 through 8 (8, 26, 28, 42, 47). The MHV
polymerase gene is depicted, and the broken line in ORF la indicates
that the actual size of this genetic domain is much larger than
illustrated. PCR-amplified DNAs spanning the C terminus of ORF la
and the entire ORF lb region were obtained by using MHV-specific
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TABLE 3. Nucleotide locations of the MHV A59 ts alleles
Amino acid
ts mutant nt site nt change change'
(location in genome)
wt ts/rev wt ts/rev
Group F (S gene)
NC6 620 A G Tyr Cys
NC6R1 A Tyr
NC6R2 A Tyr
LA7 1264 G T Ala Ser
LA7R1 G Ala
LA7R2 G Ala









LA9 355 G A Asp Asn
LA9R1 G Asp
LA9R2 G Asp
Group EB (ORF lb)
LA18 7100 G A Arg Lys
LA18R1 G Arg
LA18R2 G Arg
NC4 8427 G C Ser Thr
NC4R1 G Ser
NC4 8429 C G Leu Val
NC4R1 C Leu
a wt, wild type; ts, temperature-sensitive mutant; rev, revertant.
b Sequence reported by Bredenbeck et al. (9).
A-to-G transition at nt 620. The mutation had uniformly
reversed to A in revertant viruses. The mutation at nt 620
resulted in a nonconservative replacement of Tyr (TAC) to Cys
(TGC) at amino acid 207 in the S glycoprotein of NC6 (Table
3 and Fig. 2). LA7 also contained a single nucleotide change at
position 1264 in the Sl domain which was tightly linked to the
ts phenotype, a G-to-T transversion which resulted in a con-
servative amino acid change from Ala (GCC) to Ser (TCC) at
amino acid 422 (Table 3). In LA7 revertants, this nucleotide
change also had reversed to the original wild-type sequence.
NC16 contained a single nucleotide change involving a C-to-G
transversion at nt 2502 in the S2 domain of the S glycoprotein
gene which was linked to the ts phenotype and resulted in a
conservative amino acid change from Asp (GAC) to Glu
(GAG). In revertants of NC16, the mutation had reversed to
the parental wild-type sequence (Table 3). The location and
orientation of these ts mutants in the S glycoprotein gene
closely approximated their position as predicted from the
genetic recombination map reported previously (15). Several
additional nucleotide changes were also noted in each mutant
and revertant which were not linked to the ts phenotype (Table
4).
Sequence analysis of the RNA- ts and revertant viruses. The
group E RNA- mutants had previously mapped near the 3'
end of the polymerase gene by genetic recombination mapping
techniques (5). NC4 contained two nucleotide changes near
the 3' end of the polymerase gene at nt 8427 (G to C) and 8429
(C to G) that were tightly linked to the ts phenotype. The
mutation at 8427 (C to G) resulted in the replacement of a Ser
(AGC) with a Thr (ACC), while the mutation at nt 8429 (C to
G) resulted in a Leu (CTA) to Val (GTA) change. Collectively,
both mutations were conservative and resulted in changes at
amino acids 2728 and 2729 in ORF lb, respectively (Table 3).
Since both nucleotides had changed back to the original
wild-type sequence in the NC4 revertant and NC4 comple-
ments all other ts mutants except several group E mutants,
these data suggested that NC4 contained a double mutation
affecting the group E genetic function. LA18 contained a single
nucleotide substitution at nt 7100, which was tightly linked to
the ts phenotype and located about 1.4 kb from the 3' end of
the polymerase gene. The G-to-A transition led to a conser-
vative change from Arg (AGA) to Lys (AAA) at amino acid
2286 in ORF lb. In all revertants of LA18, the mutation had
reverted to the wild-type sequence (Table 3, Fig. 2).
Among the group C RNA- mutants which were thought to
contain mutations near the ORF la/lb boundary by genetic
recombination mapping techniques (5), LA9 contained a single
nucleotide change at nt 355 in the ORF lb domain which was
tightly linked to the ts phenotype. The mutation resided within
the ribosomal frameshifting site which regulates expression of
the ORF lb polyprotein (9). The G-to-A transition resulted in
a nonconservative alteration from Asp (GAC) to Asn (AAC).
In revertant viruses, the altered nucleotide had reversed back
to the wild-type sequence (Table 3). NC3 contained two
directly adjacent nucleotide alterations at nt 171 and 172 in
ORF la which were tightly linked to the ts phenotype. The
mutations were located just 65 nt upstream from the ribosomal
frameshifting site between ORF la and ORF lb (9). The
alteration (GC to CG) resulted in a nonconservative change
from Gly (GGC) to Ala (GCG) at amino acid 4438 in ORF la
(29). In revertant viruses, both mutations had changed to the
wild-type MHV-A59 sequence (Table 3).
In addition to the identification of mutations which were
closely linked to the ts phenotype, additional nucleotide
changes were found in both ts and revertant viruses (Table 4).
All of these alterations resulted either in silent mutations that
did not change the protein sequence or in nucleotide changes
that existed in both ts and revertant viruses.
Establishing precise recombination rates in the MHV A59
genome. Recombination frequencies between some of the
individual ts mutants sequenced in this study have been
previously reported (5, 15). However, additional recombina-
tion mapping experiments were necessary to completely en-
compass the spectrum of available crosses between these
different combinations of mutants. Each mutant was crossed
three to seven times with the other mutants used in the study
and standardized to the standard cross. Recombination fre-
quencies are expressed as mean + standard deviation (Table
5).
To standardize recombination rates across known distances
between highly defined ts alleles, the nucleotide distances
between different ts alleles (Table 6) were divided by each
individual recombination frequency recorded between a par-
ticular cross (n = 3 - 7). The standardized 1% recombination
rate was then calculated in mean base pairs ± standard
deviation for each cross (Table 7). The overall 1% recombina-
tion rate across different domains in the MHV genome was
calculated by averaging each standardized recombination rate
recorded from all of the available crosses involving mutants
which mapped in either the S glycoprotein gene (LA7, NC6,
and NC16), the polymerase gene (LA9, NC3, LA18, and NC4),
VOL. 68, 1994
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TABLE 4. Additional mutations in MHV A59 ts
and revertant viruses
Location in nt change' Amino acid
ts mutant genome change
(nt) wt ts rev wt ts rev
Group F (S gene)
NC6 131 A C C Glu Asp Asp
NC6 514 C T C Gln Gln Gln
LA7 2069 G C G Gln Gln Gln
NC16 2242 T C T Tyr Tyr Tyr
NC16 2275 G C G Gly Gly Gly
Group C/Eb (ORF lb)
NC3 209 A G G Glu Val Val
LA9 3056 G A G Leu Leu Leu
LA18 7112 C T T Ser Phe Phe
a wt, wild type; ts, temperature-sensitive mutant; rev, revertant.
b Sequence as reported by Bredenbeck et al. (9).
AC C, T
0.0001) and between rates spanning the 5' end of the S gene
and 3' end of polymerase gene as compared to rates within the
polymerase gene (P < 0.02) or the S glycoprotein gene (P <
0.0001). To account for the presence of the double ts pheno-
type that would not be detected under our recombination assay
conditions (15), the average recombination rate in base pairs
would probably be twofold the reported average values (Fig.
3).
DISCUSSION
FIG. 2. Identification of mutations linked to the ts phenotype.
Intracellular RNA was isolated from cells infected with ts or revertant
viruses, PCR amplified, and sequenced as described in Materials and
Methods. The arrows designate the locations of specific mutations
linked to the ts phenotype. (A) LA18 revertant R1; (B) group E
mutant LA18; (C and D) NC6 revertants Rl and R2, respectively; (E)
group F mutant NC6. The gels are read from the bottom.
or both domains (NC4, LA18, LA7, NC6, and NC16). Within
the S glycoprotein gene the overall average recombination rate
was measured as 1%/1,133 ± 762 bp (n = 18) compared with
an average mean recombination rate of 1%/5,393 + 3,558 bp
(n = 28) within the polymerase gene. Between the 5' end of
the S glycoprotein gene (group F: NC6, LA7, and NC16) and
the 3' end of the polymerase gene (group E: NC4 and LA18),
the average recombination rate was 1%/3,192 ± 1,792 bp (n =
22) (Table 7 and Fig. 3). Statistically significant differences
were detected between the rates of recombination measured
within the S glycoprotein gene and the polymerase gene (P <
We have isolated and characterized a panel of ts mutants of
MHV A59 which were divided into five RNA- complementa-
tion groups and one RNA' complementation group and have
been mapped by standard genetic recombination techniques
(5, 15, 43). These studies have suggested that the RNA- and
the RNA' complementation groups of MHV resided within
the 22-kb polygenic polymerase region at the 5' end of the
genome and the S glycoprotein gene, respectively, and sug-
gested that the recombination frequency of MHV was among
the highest in the nonsegmented RNA viruses (5, 14, 15, 27).
In this study, ts and revertant viruses were sequenced to
identify specific mutations which correlated with the ts pheno-
type. While this approach suffers from the practical limits of
sequencing the entire 32-kb genome in each mutant and the
lack of infectious vectors to prove whether a specific mutation
encodes the ts phenotype, a variety of data suggest that the
mutations identified in this study are tightly linked to and
probably represent the ts allele. Each mutation was present in
ts but not in revertant viruses. In each case, the location of the
ts allele corresponded to its putative domain as predicted by
standard genetic recombination mapping techniques (5, 15).
For example, the predicted orientation and location of the
RNA' mutants, 5'-NC6-LA7-NC16-3', was confirmed by se-
quence analysis with NC6 and LA7 residing in the Si domain
and NC16 in the S2 domain of the S glycoprotein gene. The
location of mutants in both the C and E complementation
groups were also close to the site predicted from the genetic
recombination map (5). Importantly, RNA recombinant vi-
ruses, isolated between LA7 and wild-type JHM following
selection at 39°C, contained crossover sites which were within
100 bp of (25%) or completely replaced (75%) the LA7
mutation with heterologous JHM sequences (3, 33). While
these data provide a strong link between individual mutations
B
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TABLE 5. Recombination frequencies between MHV-A59 ts mutants'
Recombination frequencyb
Mutant
NC3 LA18 NC4 NC6 LA7 NC16
LA9 0.1 + 0.09 3.1 + 1.80 2.2 0.56 5.13 +0.97 4.5 +0.80 ND
NC3 0.84 ± 0.21 1.67 ± 0.70 5.5 ± 2.10 3.74 ± 2.30 ND
LA18 0.91 ± 0.90 0.9 + 0.20 1.2 + 0.30 4.6 ± 0.60
NC4 0.78 ± 0.21 1.40 ± 0.40 1.30 0.10
NC6 0.2 ± 0.02 2.8 ± 0.90
LA7 3.0 ± 1.20
'N = 3 to 7.
b Mean ± standard deviation. ND, not done.
and the ts allele, definitive proof must await the development
of MHV infectious clones.
The ts mutants utilized in this study were isolated in separate
experiments using either 5-fluorouracil (LA18 and NC16) or
5-azacytidine (LA7, NC6, NC3, NC4, and LA9) as mutagen
and caused point mutations that result in conservative (struc-
turally similar) or nonconservative (structurally dissimilar)
amino acid changes in the protein sequence (43). Interestingly,
5-fluorouracil, which should result in changes from T(U) or A
to other nucleotides (G or C) in the RNA sequence, was not
detected in LA18 and NC16. In contrast, 5-azacytidine, which
causes a substitution of C or G with other bases, was evident in
ts LA7, NC4, LA9, and NC3 but not in NC6. Similar results
were reported with Sindbis virus ts mutants in which the
mutation could not always be equated with the mechanism of
action of the selecting mutagen, suggesting that the mutation
may have been caused by RNA polymerase error (17, 18).
It is well documented that viral RNA-dependent RNA
polymerases do not contain proofreading capabilities and,
consequently, have high mutation rates approaching 10' to
10-5 per round of replication (19). Not surprisingly, ts mutants
ofRNA viruses also have reversion frequencies on the order of
10-3 to 10-5 (25, 29, 34, 43). In the case of polio and Sindbis
viruses, reversion to the wild-type phenotype is normally
accompanied by reversion at the site of mutation (17, 18, 23).
In contrast, ts mutants of double-stranded RNA viruses like
reoviruses often revert from attenuating second site mutations
(40). In this study, all of the MHV ts mutants, including those
with double mutations, reverted to the wild-type sequence at
the site of mutation. Reversion frequencies were usually lower
when single rather than double nucleotide changes were
required for reversion to the ts+ phenotype (Table 2). How-
ever, NC3 contained a double mutation resulting in a single
amino acid change in ORF la, yet surprisingly, it had relatively
high reversion frequencies on par with other mutants that
contained single nucleotide changes. Sequence analysis of the
wild-type and NC3 genomes indicates that a single or double
nucleotide substitution at either the second and third positions
or the third position only in the triplet code could result in a
wild-type ts+ phenotype (MHV-A59-Ala [GCG]; NC3-Gly
[GGC]; NC3R1 or NC3R2 revertants-Ala [GCG]; putative
ts+ revertant-Ala [GCC]). It is less clear why the NC3 rever-
tants had completely returned to the wild-type sequence at
both positions unless the primary sequence provided some
selective advantages following two plaque purifications and the
generation of virus stocks. In contrast, NC4 also contained a
double mutation in the group E genetic function which altered
two amino acids near the C terminus of ORF lb, and rever-
tants of this virus were virtually impossible to isolate until it
had been serially passaged at semipermissive and restrictive
temperatures. While we do not have direct evidence, NC4
probably changed to the wild-type phenotype by the accumu-
lation of two independent reversion events which occurred
during serial passage.
Although coronavirus polymerase error rates have not been
rigorously examined, mutation and reversion frequencies of
MHV-A59 and MHV-JHM ts mutants generally range from
10-3 to 10-5, suggesting that proofreading activities were not
present in the MHV polymerase (25, 29, 34, 43). From highly
plaque-purified ts mutants requiring a single nucleotide alter-
ation at the site of mutation for reversion to the ts+ phenotype
(LA9, NC3, LA18, NC6, NC16, and LA7), we calculated the
average polymerase error rate in the MHV genome to ap-
proach 1.32 x 10-4 ± 0.89 x 10-4, or about 2.4 mutations per
genome round of replication (range, 1.5 to 7.4). This is similar
to error rates calculated for other positive-strand RNA viruses
(19, 36, 52). It has been suggested that the MHV polymerase
may contain a ribonuclease activity which trims leader RNA
mismatches at intergenic start sites during "leader-primed"
transcription and may also encode an RNA editing function (2,
21). If proofreading or editing activities are encoded in the
MHV polymerase, our data suggest that they probably function
poorly or not at all in the repair of mismatches incorporated
into nascent chains during RNA transcription.
The MHV genomic RNA contains two large ORFs at the 5'
end, and ORF lb is translated by ribosomal frameshifting as a
large ORF la/lb polyprotein which is subsequently cleaved by
cellular or viral proteases into individual viral proteins (8, 9,
28). It is not clear whether functional viral proteins are
encoded which span the ORF la/lb junction (28). Previous
studies in our laboratory suggest that the group C and E
RNA- mutants encode genetic functions regulating negative-
and positive-strand RNA synthesis, respectively (43). The
group E genetic function is located between nt 7100 and nt
8427 (amino acids 2274 to 2728 in ORF lb), while the group C
function probably spans the ORF la/lb ribosomal frameshift-
ing site since NC3 and LA9 are located at the C and N termini
of ORF la and ORF lb, respectively (Fig. 4). These data
clearly demonstrate that genetic alleles in ORF lb function in
TABLE 6. Distances between ts alleles
Distance (nt)
Mutant
NC3 LA18 NC4 NC6 LA7 NC16
LA9 183 6,845 8,172 10,896 11,540 12,778
NC3 7,028 8,355 11,079 11,723 12,961
LA18 1,327 4,151 4,795 6,033
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TABLE 7. Standardized 1% recombination frequency between different combinations of MHV-A59 ts mutants
Recombination frequencya
Mutant
NC3 LA18 NC4 NC6 LA7 NC16
LA9 6,718 ± 6,093 2,962 ± 1,410 3,930 ± 787 2,145 ± 355 2,683 ± 460 ND
NC3 8,979 ± 1,191 6,006 + 2,041 2,214 + 658 4,399 ± 2,238 ND
LA18 4,199 ± 3,274 4,723 ± 450 4,508 + 1,728 1,054 ± 139
NC4 3,964 ± 1,357 2,723 ± 878 3,721 ± 313
NC6 2,169 ± 1,031 629 ± 331
LA7 615 ± 234
a In mean base pairs ± standard deviation. ND, not done.
RNA synthesis. More mutants must be sequenced before
reliable estimates of the size and exact location of the func-
tional domains of the group C and E complementation groups
can be determined. Since the location of the NC3 and LA9
mutations are not in regions demonstrated to block ribosomal
frameshifting in infectious bronchitis virus (11), it is possible
that the mutations may ablate proteolytic processing of one or
more N-terminal ORF lb polyproteins (9, 28).
Previous studies in our laboratory have predicted that the
overall RNA recombination rates in the polymerase and S
glycoprotein genes of MHV approached 1%/1,800-2,500 bp
and 1%/575-667 bp, respectively (5, 15). The physical map
locations of the seven mutants sequenced in this study allowed
us to determine precise recombination rates across defined
distances. In the polymerase and S glycoprotein genes, the
average recombination rates were about 1%/5,393 ± 3,558 bp
and 1%/1,133 ± 762 bp; respectively, which were significantly
different (P < 0.0001). Recombination rates measured from
the-S glycoprotein gene to the polymerase gene approached
1%/3,192 ± 1,792 bp, and this was significantly different from
rates calculated in either the polymerase (P < 0.02) or S (P <
0.0001) glycoprotein genes. Assuming that recombination
events occur in both directions and result in the double ts
phenotype, these results closely parallel previous predictions
and clearly demonstrate that variable rates of recombination
occur within different regions of the MHV genome. Using the
markers identified in this study, we can also predict the overall
recombination frequency in different portions of the MHV
genome. Assuming that recombination events also result in the
double ts phenotype, recombination frequencies approach
8.2% in the 22-kb polymerase gene, -1.4% across the p30/HE
genes (-2.2 kb), and -7.1% across the -4.0-kb S glycoprotein
gene (Fig. 3). While markers are not available to measure the
recombination frequency at the 3'-most -4.0 kb of the viral
genome, it has previously been demonstrated that recombina-
tion events at the 3' end of the genome can be detected in the
absence of selective markers (20). Thus, it seems likely that the
recombination frequency will approach or exceed rates in the
S glycoprotein gene, approximately 7 to 8% or more.
Several explanations could account for the increase in the
rate of recombination within the MHV genome, including high
negative interference, preferred "hot spots" of recombination,
and the presence of nested set subgenomic negative strands
and subgenomic mRNA which increase the amount of avail-
able template for switching (15, 24). High negative interfer-
ence seems unlikely since recombination frequencies did not
increase as the physical distance between two ts alleles de-
creased and RNA repair mechanisms have not been demon-
strated in MHV (16). Since a progressive, statistically signifi-
cant increase in the recombination rate was detected from the
5' to the 3' end of the genome, these findings are inconsistent
with recombination hot spots which predict that similar rates of
recombination will be detected 5' and 3' to the preferred site.
Extensive sequence analysis of RNA recombinant viruses also
supports the notion of non-site-specific homologous recombi-
nation or the idea that crossover events may occur near UU
dimers or in regions of secondary structure in sites chosen to
minimize the adverse free energy change involved in template
switching (4, 13, 22). It has been reported that a preferred site
of recombination exists in MHV between nt 1146 and 1431 in
the S glycoprotein gene (3). The locations of the two ts mutants
LA7 (nt 1264) and LA12 (located -0.2 recombination units
from LA7, or about 250 bp) and the monoclonal antibody
neutralization sites (near the C-terminal domain of Si at nt
1766 or 1950) used to select these recombinants have now been
identified (54); the actual distance between the two selective
markers was only about 0.5 to 0.8 kb. It seems more likely
that the clustering of recombination sites in the S glycopro-
tein gene was defined by the selective markers used in the
study (3).
A more likely explanation for different rates of recombina-
tion in the MHV genome is the presence of transcriptionally
active subgenomic negative strands and nested set mRNAs
which effectively increase the amount of template RNA which
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FIG. 3. Recombination rates in different portions of the MHV
genome. The relative locations of the MHV-A59 ts mutants are
superimposed upon the genetic organization and transcriptional strat-
egy of MHV. The group C RNA- mutants, NC3 and LA9, flank the
ribosomal frameshifting site (hatched region) delineating ORF la and
ORF lb (9). Standardized 1% recombination rates were determined
across the indicated areas as described in Materials and Methods.
Overall predicted recombination frequencies for different regions of
the MHV genome are shown at the bottom of the figure.
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FIG. 4. The location of the group C mutants with respect to the
ribosomal frameshifting site. ORF la and ORF lb represent the two
large ORFs in the polymerase gene of MHV. The locations of the
mutations in LA9 and NC3 are shown relative to the ribosomal
frameshifting site (9) and putative poliovirus 3C-like protease cleavage
sites (28). These data suggest that complementation group C spans the
ORF la/lb junction.
this hypothesis, in vitro transcribed mRNAs and 5'-truncated
RNA products that were transfected into infected cells partic-
ipated in recombination (24, 30). In addition, recombinant
viruses have also been isolated from persistently infected cells
which contain leader RNA sequences inserted into the
genomic RNA at highly conserved intergenic sequences sug-
gesting that recombination events occurred between sub-
genomic-length and full-length mRNA or negative-stranded
RNAs (51). Recombination has also been demonstrated be-
tween genome-length RNA and subgenomic-length defective
interfering RNAs, indicating that differentially sized templates
can participate in RNA recombination (53).
The high rate of coronavirus RNA recombination coupled
with high polymerase error rates would not only provide a
natural mechanism for rapid antigenic variation and evolution
within the highly immunogenic structural genes but, as with
influenza virus, suggests that these viruses possess significant
latent capacity as emerging pathogens (36). Coronaviruses
cycle through the human population every couple of years,
causing 15 to 20% of the common colds in winter. Occasion-
ally, they are associated with lower respiratory tract infections
like bronchitis and pneumonia, and they have been implicated
in perimyocarditis and infections of the central nervous system,
including multiple sclerosis (37, 49). It is also clear that MHV
can rapidly alter its species specificity and infect rats and
primates in vivo. The resulting variant viruses produce enceph-
alitis or demyelination in the new host (35, 38). Newly recog-
nized animal coronaviruses include porcine respiratory disease
virus and porcine epidemic diarrhea coronavirus (10, 12).
Porcine respiratory disease virus probably evolved from por-
cine transmissible gastroenteritis virus by mutation and recom-
bination, resulting in numerous deletions and mutations in
structural and nonstructural genes (12). In contrast, porcine
epidemic diarrhea coronavirus is more closely related to the
human coronavirus 229E than porcine transmissible gastroen-
teritis virus, suggesting that it may have evolved from or
recombined with human strains (10). The high mutation and
RNA recombination rates of coronaviruses suggest that these
viruses have the potential to evolve rapidly, transverse the
species barrier under the appropriate conditions, and emerge
as major pathogens associated with significant morbidity and
mortality.
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